Anno2015
AutoriLeiva R.; Gazzarrini S.; Esplugas R.; Moroni A.; Naesens L.; Sureda F.X.; Vazquez S.
AbstractTwo alternative syntheses of 2-oxaadamantan-5-amine, a novel analog of the clinically approved drug amantadine, are reported. The compound has been tested as an anti-influenza A virus agent and as an NMDA receptor antagonist. While the compound was not antivirally active, it displayed moderate activity as an NMDA receptor antagonist.
RivistaTetrahedron Letters
ISSN0040-4039
Impact factor0
Volume56
Pagina inizio1272
Pagina fine1275
Autori IBFAnna MORONI
Linee di Ricerca IBFMD.P01.005.001
Sedi IBFIBF.MI